CAM
NVO

CenterStar Asset Management’s Novo Nordisk NVO Stock Holding History

CenterStar Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,807
Closed -$617K – 451
2026
Q1 		$617K Buy
+16,807
New +$796K 0.08% 285
2018
Q2 		– Hold
0
– – – 425
2018
Q1 		– Hold
0
– – – 478

Other funds holding NVO

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
MCP
Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EIA
Eastover Investment Advisors Charlotte, North Carolina $257M AUM 14.8% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM

CenterStar Asset Management's NVO Position: Q2 2026 in Review

CenterStar Asset Management sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 16,807 shares — an estimated $617K sold.

CenterStar Asset Management first reported a position in NVO in Q1 2026 and held it in 1 quarter. The position peaked at $617K in Q1 2026. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • CenterStar Asset Management reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • CenterStar Asset Management sold 16,807 Novo Nordisk shares in Q2 2026, an estimated $617K.
  • CenterStar Asset Management first reported a position in Novo Nordisk in Q1 2026 and held it in 1 quarter.
  • CenterStar Asset Management's Novo Nordisk position peaked at $617K in Q1 2026.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on CenterStar Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.